DELOITTE CONSULTING LLP
Federal contract award, Deloitte, $5,566,265
Key CONT_AWD_75F40122F19001_7524_75F40121A00003_7524. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 410 days before this system saw it. One version on record.
Cite this row
8e3978bf8bb0301dcafccaa291e482a9fedd2eea7277472e80ea923da7d9996eThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $5,566,265 | first version | November 30, 2021 | July 22, 2025 | 2026-09-05T00:50:08Z | historical sweep | 8e3978bf8bb0 |
Archived copy
None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.
What the amount is made of
14 recorded actions, so the amount is the award's current total across all of them. 8 of them obligated money. Measured 2026-10-21, when USAspending reported a total obligation of $5,566,265.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| July 22, 2025 | P00013 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | −$973,183 | EOI::TOP 10 CONSULTING FIRMS::EOI NOTICE OF TERMINATION FOR CONVENIENCE AGREEMENT - FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| April 1, 2025 | P00012 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | no money | EOI::TOP 10 CONSULTING FIRMS::EOI NOTICE OF TERMINATION FOR CONVENIENCE |
| December 11, 2024 | P00011 | EXERCISE AN OPTION | +$1,255,721 | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| June 5, 2024 | P00010 | FUNDING ONLY ACTION | no money | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| December 26, 2023 | P00009 | EXERCISE AN OPTION | +$1,568,385 | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| July 31, 2023 | P00008 | FUNDING ONLY ACTION | +$385,267 | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| May 1, 2023 | P00007 | FUNDING ONLY ACTION | +$487,731 | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| December 20, 2022 | P00006 | OTHER ADMINISTRATIVE ACTION | +$1,377,831 | FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| August 18, 2022 | P00005 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$272,449 | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| May 17, 2022 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| March 25, 2022 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| March 21, 2022 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| December 8, 2021 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
| November 30, 2021 | base | not on file | +$1,192,065 | E014042 FDA ENTERPRISE RISK MANAGEMENT PROGRAM SUPPORT |
Last refreshed November 4, 2026 at 2:31 PM UTC.